Evidence map›Paper›PMID 42813370›Full record

ArticleNucleic acids research2026

CUT&ID for simultaneous profiling of protein-DNA and protein-protein interactions.

Anna Nordin, Claudio Cantù

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anna NordinWallenberg Centre for Molecular Medicine, Linköping University, SE-581 83 Linköping, Sweden.ORCID 0000-0002-5868-4797
Claudio CantùWallenberg Centre for Molecular Medicine, Linköping University, SE-581 83 Linköping, Sweden.ORCID 0000-0003-1547-5415

Funding

Additional Ventures SVRF2021-1048003Cancerfonden 21 1572 PjCancerfonden 24 3487 PjKnut and Alice Wallenberg FoundationKnut och Alice Wallenbergs StiftelseLinköping UniversityLiU/RÖ CancerSwedish Research Council 2021-03075Swedish Research Council 2023-01898Swedish Research Council 2025-02369Wallenberg Centre for Molecular Medicine
6 · The paper itself

Abstract

We developed CUT&ID to simultaneously profile the native genomics and proteomics associations of any endogenous target, in a single workflow with no need for transgenesis. CUT&ID is enabled by a fusion protein of TurboID, protein A/G, and micrococcal nuclease, which drives sequential target recognition, proximal protein biotinylation, and DNA cleavage in living cells. CUT&ID is broadly applicable, works on fresh, frozen, or fixed nuclei, and provides high signal-to-noise genomics and proteomics identification across all types of gene regulators tested, including histone modifications, transcription factors, and non-DNA-binding proteins. CUT&ID's streamlined protocol yields a dual readout from 1 million cells per sample, making it an attractive alternative to existing methodologies.

Indexed as

DNADNA-Binding ProteinsGenomicsProteomicsAnimalsHumansMicrococcal NucleaseProtein BindingRecombinant Fusion ProteinsDNADNA-Binding ProteinsMicrococcal NucleaseRecombinant Fusion Proteins

Identifiers

PMID42813370
PMCPMC13624661

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.